articleThe LancetMay 1, 2009GREEN OA

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Medical University of Vienna · Instituto do Câncer do Estado de São Paulo · +14 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,355
total citations
FWCI
158.26
Percentile
100%
References
28
Citations per year

Authors

18

Topics & keywords

Keywords
  • Cetuximab
  • Medicine
  • Chemotherapy
  • Vinorelbine
  • Lung cancer
  • Internal medicine
  • Hazard ratio
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding